This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Christ-siemens-touraine Syndrome
Information about Christ-siemens-touraine Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Christ-siemens-touraine Syndrome
Most recent studies have shown that Christ-siemens-touraine Syndrome shares some biological mechanisms with anhydrotic-ectodermal-dysplasias, bloch-sulzberger-syndrome, congenital-abnormality, congenital-absence, congenital-disorders, developmental-absence-of-tooth, dry-skin, dysplasia, ectodermal-dysplasia, ectodermal-dysplasia-hypohidrotic-autosomal-recessive, genetic-diseases-x-linked, hereditary-diseases, hypodontia, hypohidrosis, hypoplasia, hypotrichosis, immunologic-deficiency-syndromes, infective-disorder, tooth-abnormalities, tooth-loss.
Among the many pathways, these few ones have gauged particular interests from scientists studying Christ-siemens-touraine Syndrome, and have been seen in publications frequently: Anagen, Appendage Morphogenesis, Bone Maturation, Cell Activation, Cell Adhesion, Cell Differentiation, Cell Maturation, Cell Proliferation, Cognition, Developmental Process, Gland Development, Hair Follicle Development, Localization, Mastication, Odontogenesis, Pathogenesis, Reflex, Secretion, Spermatogenesis, Sweat Gland Development
Quite a number of genes have been found to play important roles in Christ-siemens-touraine Syndrome, such as EDA, EDA2R, EDAR, EDARADD, EGF, GJB6, HAND2, IKBKG, NFKB1, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.